Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.

Genes - 23 Jul 2022

Paderina Diana Z, Boiko Anastasiia S, Pozhidaev Ivan V, Mednova Irina A, Goncharova Anastasia A, Bocharova Anna V, Fedorenko Olga Yu, Kornetova Elena G, Semke Arkadiy V, Bokhan Nikolay A, Loonen Anton J M, Ivanova Svetlana A

Abstract excerpt

BACKGROUND: Metabolic syndrome is widespread in patients with schizophrenia receiving long-term antipsychotic therapy. Dopamine D2 receptors play an important role in mediating both the therapeutic actions of antipsychotics and their side effects. The present study examined the association of two polymorphisms of the DRD2 gene with metabolic syndrome in patients with schizophrenia. METHODS: We examined 517...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Metabolic Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Quality of Life

Share to Receptors, Dopamine D2

Share to Schizophrenia

Share to Schizophrenia research and treatment

Share to Sex Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 35893053
DOI: 10.3390/genes13081312
PMCID: PMC9331510

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.PMID 35893053Read ↗

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.Semantic proximity Read ↗

HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With SchizophreniaSemantic proximity Read ↗

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Semantic proximity Read ↗

Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophreniaSemantic proximity Read ↗

Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.Semantic proximity Read ↗

Association between the DRD2-141C Insertion/Deletion polymorphism and schizophrenia.Semantic proximity Read ↗

Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.Semantic proximity Read ↗

Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsSemantic proximity Read ↗

Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic TreatmentSemantic proximity Read ↗

Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphismsSemantic proximity Read ↗

The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis.Semantic proximity Read ↗

Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.